Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still’s Disease From COVID-19

BACKGROUND: Hyperinflammation with dysregulated production of galectins and cytokines may develop in COVID-19 or adult-onset Still’s disease (AOSD). Given the similar clinical features in both diseases, it is necessary to identify biomarkers that can differentiate COVID-19 from AOSD. However, the re...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Po-Ku, Lan, Joung-Liang, Huang, Po-Hao, Hsu, Jye-Lin, Chang, Ching-Kun, Tien, Ni, Lin, Hui-Ju, Chen, Der-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343229/
https://www.ncbi.nlm.nih.gov/pubmed/34367188
http://dx.doi.org/10.3389/fimmu.2021.719544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8343229/
https://www.ncbi.nlm.nih.gov/pubmed/34367188
http://dx.doi.org/10.3389/fimmu.2021.719544

Ejemplares similares